Reset
Id
Protein
PTM type
Site
Species
Disease
Cell line
Drug
Regulatory
Confidence score(level)
Ref.
acc2001 STAT3 phosphorylation Tyr705 human Medulloblastoma UW228 SPARC OE Associated 3.0 (Low) 21613407
acc2002 STAT3 phosphorylation Tyr705 human Medulloblastoma D425 SPARC OE Associated 3.0 (Low) 21613407
acc2003 STAT3 phosphorylation Tyr705 human Medulloblastoma H2405 SPARC OE Associated 3.0 (Low) 21613407
acc2004 STAT3 phosphorylation Tyr705 human Medulloblastoma H2411 SPARC OE Associated 3.0 (Low) 21613407
acc2005 STAT3 phosphorylation Tyr727 human Medulloblastoma Daoy SPARC OE Associated 3.0 (Low) 21613407
acc2006 STAT3 phosphorylation Tyr727 human Medulloblastoma D283 SPARC OE Associated 3.0 (Low) 21613407
acc2007 STAT3 phosphorylation Tyr727 human Medulloblastoma UW228 SPARC OE Associated 3.0 (Low) 21613407
acc2008 STAT3 phosphorylation Tyr727 human Medulloblastoma D425 SPARC OE Associated 3.0 (Low) 21613407
acc2009 STAT3 phosphorylation Tyr705 human Colorectal Cancer HCT116 Doxorubicin Enhancing 5.0 (High) 20026083
acc2010 STAT3 phosphorylation Tyr705 human Breast Cancer MDA-MB-231 Doxorubicin Enhancing 5.0 (High) 20026083
acc2011 STAT3 phosphorylation Tyr705 human Ovarian Cancer HeLa Doxorubicin Enhancing 5.0 (High) 20026083
acc2012 STAT3 phosphorylation Tyr705 human Hepatocellular Carcinoma HepG2 Doxorubicin Enhancing 5.0 (High) 20026083
acc2013 PIN1 phosphorylation Ser115 human Cholangiocarcinoma Retinoic acid Associated 4.0 (Moderate) 34048060
acc2014 JNK1 phosphorylation Thr183 human Hepatocellular Carcinoma HuH-7 Resveratrol Associated 4.0 (Moderate) 23437203
acc2015 JNK1 phosphorylation Tyr185 human Hepatocellular Carcinoma HuH-7 Resveratrol Associated 4.0 (Moderate) 23437203
acc2016 JNK2 phosphorylation Thr183 human Hepatocellular Carcinoma HuH-7 Resveratrol Associated 4.0 (Moderate) 23437203
acc2017 JNK2 phosphorylation Tyr185 human Hepatocellular Carcinoma HuH-7 Resveratrol Associated 4.0 (Moderate) 23437203
acc2018 KIT phosphorylation Tyr703 human Lung Cancer HCC78 Crizotinib + Ponatinib Associated 4.0 (Moderate) 27068398
acc2019 KIT phosphorylation Tyr703 human Lung Cancer CUTO2 Crizotinib + Ponatinib Associated 4.0 (Moderate) 27068398
acc2020 STAT3 phosphorylation Tyr705 human Hepatocellular Carcinoma HepG2 xenografts Sorafenib + Cucurbitacin B Impairing 5.0 (High) 33176070
acc2021 LASP1 phosphorylation Tyr171 human Leukemia BV173 Nilotinib Associated 3.0 (Low) 24913448
acc2022 AMPK phosphorylation Thr172 human Breast Cancer MCF7 Docosahexaenoic acid (DHA) Associated 4.0 (Moderate) 24025358
acc2023 AMPK phosphorylation Thr183 human Breast Cancer MCF7 Docosahexaenoic acid (DHA) Associated 4.0 (Moderate) 24025358
acc2024 BIM phosphorylation unclear human Leukemia SUPT-1 Prednisolone Impairing 5.0 (High) 34007050
acc2025 ERK1 phosphorylation Thr202 human Melanoma SB01-VR Bafetinib Associated 4.0 (Moderate) 29717260
acc2026 ERK1 phosphorylation Tyr204 human Melanoma SB01-VR Bafetinib Associated 4.0 (Moderate) 29717260
acc2027 ERK2 phosphorylation Thr185 human Melanoma SB01-VR Bafetinib + Trametinib Associated 4.0 (Moderate) 29717260
acc2028 ERK2 phosphorylation Tyr187 human Melanoma SB01-VR Bafetinib + Trametinib Associated 4.0 (Moderate) 29717260
acc2029 ERK2 phosphorylation Thr185 human Melanoma SB01-VR Bafetinib Associated 4.0 (Moderate) 29717260
acc2030 ERK2 phosphorylation Tyr187 human Melanoma SB01-VR Bafetinib Associated 4.0 (Moderate) 29717260
acc2031 ERK1 phosphorylation Thr202 human Melanoma SB01-VR Trametinib Associated 4.0 (Moderate) 29717260
acc2032 ERK1 phosphorylation Tyr204 human Melanoma SB01-VR Trametinib Associated 4.0 (Moderate) 29717260
acc2033 ERK2 phosphorylation Thr185 human Melanoma SB01-VR Trametinib Associated 4.0 (Moderate) 29717260
acc2034 ERK2 phosphorylation Tyr187 human Melanoma SB01-VR Trametinib Associated 4.0 (Moderate) 29717260
acc2035 ERK1 phosphorylation Thr202 human Melanoma SB01-VR Bafetinib + Trametinib Associated 4.0 (Moderate) 29717260
acc2036 ERK1 phosphorylation Tyr204 human Melanoma SB01-VR Bafetinib + Trametinib Associated 4.0 (Moderate) 29717260
acc2037 MEK1 phosphorylation Ser217 human Breast Cancer MCF7 DHA Associated 4.0 (Moderate) 21771724
acc2038 MEK1 phosphorylation Ser221 human Breast Cancer MCF7 DHA Associated 4.0 (Moderate) 21771724
acc2039 MEK2 phosphorylation Ser217 human Breast Cancer SK-BR-3 DHA Associated 4.0 (Moderate) 21771724
acc2040 MEK2 phosphorylation Ser221 human Breast Cancer SK-BR-3 DHA Associated 4.0 (Moderate) 21771724
acc2041 ERK1 phosphorylation Thr202 human Breast Cancer SK-BR-3 DHA Associated 4.0 (Moderate) 21771724
acc2042 ERK1 phosphorylation Tyr204 human Breast Cancer SK-BR-3 DHA Associated 4.0 (Moderate) 21771724
acc2043 ERK2 phosphorylation Thr185 human Breast Cancer SK-BR-3 DHA Associated 4.0 (Moderate) 21771724
acc2044 ERK2 phosphorylation Tyr187 human Breast Cancer SK-BR-3 DHA Associated 4.0 (Moderate) 21771724
acc2045 MEK2 phosphorylation Ser217 human Breast Cancer MCF7 DHA Associated 4.0 (Moderate) 21771724
acc2046 MEK2 phosphorylation Ser221 human Breast Cancer MCF7 DHA Associated 4.0 (Moderate) 21771724
acc2047 ERK1 phosphorylation Thr202 human Breast Cancer MCF7 DHA Associated 4.0 (Moderate) 21771724
acc2048 ERK1 phosphorylation Tyr204 human Breast Cancer MCF7 DHA Associated 4.0 (Moderate) 21771724
acc2049 ERK2 phosphorylation Thr185 human Breast Cancer MCF7 DHA Associated 4.0 (Moderate) 21771724
acc2050 ERK2 phosphorylation Tyr187 human Breast Cancer MCF7 DHA Associated 4.0 (Moderate) 21771724